New neuroimaging technique studies brain stimulation for depression

Human mesenchymal stem cells show promise in treating chronic lung infections
4 May 2021
Do people aged 105 and over live longer because they have more efficient DNA repair?
4 May 2021

New neuroimaging technique studies brain stimulation for depression

Repetitive transcranial magnetic stimulation, or rTMS, was FDA approved in 2008 as a safe and effective noninvasive treatment for severe depression resistant to antidepressant medications. A small coil positioned near the scalp generates repetitive, pulsed magnetic waves that pass through the skull and stimulate brain cells to relieve symptoms of depression. The procedure has few side effects and is typically prescribed as an alternative or supplemental therapy when multiple antidepressant medications and/or psychotherapy do not work.

Comments are closed.